Browse the evidence

Mechanical loading induces skeletal muscle growth primarily through myofiber hypertrophy (increase in cross-sectional area) and fascicle architectural changes (increased length and pennation angle), rather than hyperplasia (increase in fiber number).

To maximize muscle growth, focus on resistance training that creates significant mechanical load. Expect your muscle fibers to get thicker (hypertrophy) and your muscle architecture to adapt (changes in fiber length and pennation angle). Do not rely on the idea that you are creating entirely new muscle fibers (hyperplasia), as evidence for this is weak and controversial.

Animal protein provides a statistically significant advantage over plant protein for increasing percent lean mass, particularly in adults under 50 years of age, while absolute lean mass and muscle strength gains are generally equivalent between sources when total protein intake is adequate.

If you are under 50, choosing animal protein over plant protein may give you a slight edge in preserving lean tissue relative to your body weight, but it won't necessarily add more absolute muscle or strength if you eat enough total protein. For older adults, the source matters less than hitting your total protein targets. Focus on getting enough protein daily rather than obsessing over animal vs. plant source for strength outcomes.

Five years of supervised high-intensity interval training (HIIT) in older adults (70-77 years) shows a non-significant trend toward reduced all-cause mortality compared to following national physical activity guidelines, whereas moderate-intensity continuous training (MICT) showed no benefit and potentially increased risk.

If you are in your 70s, simply following general activity guidelines (like daily walking) may not be enough to maximize your lifespan. Incorporating high-intensity intervals (like 4 minutes of hard effort repeated 4 times, twice a week) under supervision shows a promising trend toward lower mortality compared to moderate activity alone. However, the study was not large enough to prove this statistically, so consistency and safety are key.

High consumption of white rice (≥450 g/day) is associated with an increased risk of incident type 2 diabetes, with the strongest association observed in South Asian populations.

If you eat large amounts of white rice (more than 3 cups cooked per day), your risk of developing type 2 diabetes increases, especially if you are of South Asian descent. To reduce this risk without necessarily giving up rice, try switching to brown rice, choosing high-fiber white rice varieties, or adding legumes (beans, lentils) to your rice meals to lower the glycemic impact. Be aware that in China, this specific risk was not statistically significant, suggesting regional or varietal differences.

Single oral doses of 150–900 mg naringenin (from whole orange extract) are safe and well-tolerated in healthy adults, with serum concentrations proportional to the dose.

Taking 300mg of naringenin (from a whole orange extract) twice daily is predicted to reach effective levels (8 μM) in your body to potentially support metabolic health, and it is safe to do so. You cannot get these levels from drinking orange juice alone.

Vegan and low-fat dietary patterns, when implemented as intended, mostly align with 2021 AHA Dietary Guidance but face challenges regarding nutrient adequacy and adherence due to severe restrictions.

If you follow a vegan or low-fat diet, it can support heart health, but you must be careful about nutrient adequacy. Work with a registered dietitian to ensure you are getting enough essential nutrients, especially if you exclude animal products or fats.

Sugars are not inherently harmful; their effect on cardiometabolic health depends on energy balance and food source. Sugar-sweetened beverages cause harm due to excess energy, while sugars in high-quality foods (fruit, yogurt, whole grain cereals) provide benefit when substituted for refined starches.

Do not fear sugars in whole foods. Fruit, yogurt, and whole grain cereals containing sugars are beneficial when they replace refined starches. Avoid sugar-sweetened beverages which provide excess energy without nutrients.

SGLT2 inhibitors promote weight loss and improve metabolic parameters (blood pressure, lipid profile, uric acid) by increasing urinary glucose excretion, resulting in an energy deficit of 240-320 kcal/day.

SGLT2 inhibitors help with weight loss by excreting glucose in urine, creating a daily calorie deficit of about 240-320 kcal. This can help reduce abdominal fat and improve blood pressure and lipids. However, weight loss tends to plateau, so combining the medication with lifestyle changes is important for long-term success.

SGLT2 inhibitors lower HbA1c by 0.6-0.8% without increasing hypoglycemia risk when used as monotherapy, but require dose adjustment of insulin/secretagogues when combined.

SGLT2 inhibitors effectively lower blood sugar (HbA1c) by about 0.6-0.8% without causing low blood sugar on their own. If you are also taking insulin or sulfonylureas, your doctor may lower your dose of those medications to prevent hypoglycemia. This makes them a safer option for many patients compared to older drugs.

Time-restricted feeding (TRF) with early or midday timing improves insulin sensitivity and cardiometabolic health markers more effectively than late TRF, independent of caloric restriction.

If you practice Time-Restricted Feeding, try to eat your meals earlier in the day (e.g., 8 AM to 2 PM or 10 AM to 6 PM). This timing aligns with your body's natural circadian rhythm and has been shown to improve insulin sensitivity and blood pressure more effectively than eating the same calories later in the evening. You do not need to restrict calories strictly; simply shifting your eating window earlier can yield metabolic benefits.

Intermittent Fasting (IF) regimens (5:2, ADF, ADMF, TRF) produce weight loss comparable to daily caloric restriction (CR), but may offer superior insulin-sensitizing benefits independent of weight loss.

If you are choosing between Intermittent Fasting and daily calorie restriction for weight loss, know that both methods are equally effective for losing weight. However, IF may offer extra benefits for your metabolic health, such as better insulin sensitivity, which might be important if you have prediabetes or metabolic syndrome. Choose the method you can sustain long-term.

High body mass index (BMI) is a strong independent risk factor for the development and progression of chronic kidney disease (CKD), primarily driven by compensatory glomerular hyperfiltration and increased intraglomerular pressure.

Maintaining a healthy weight is one of the most effective ways to protect your kidneys. Excess body weight forces your kidneys to work harder (hyperfiltration), which can cause long-term damage. Focus on sustainable lifestyle changes like balanced nutrition and regular physical activity to manage weight, especially if you have a family history of kidney issues or high blood pressure.

Obesity increases the risk of kidney stones (nephrolithiasis) and kidney cancer through mechanisms involving insulin resistance, acidic urine, and adipose-derived inflammatory factors.

If you are overweight, you are at higher risk for kidney stones and kidney cancer. This is partly due to how your body processes acids and minerals. Staying well-hydrated and maintaining a healthy weight through balanced eating can help reduce these risks. Be cautious with extreme weight loss methods, as they can sometimes increase stone risk.

High baseline cardiorespiratory fitness (CRF) is independently associated with a significantly lower risk of incident heart failure (HF), particularly heart failure with preserved ejection fraction (HFpEF), in adults with type 2 diabetes.

For adults with type 2 diabetes, prioritizing cardiorespiratory fitness (CRF) is more critical for preventing heart failure than focusing solely on weight loss. Aim to improve your aerobic capacity through regular physical activity, as higher fitness levels are strongly linked to a reduced risk of heart failure, particularly the preserved ejection fraction subtype.

Resistance exercise-induced skeletal muscle hypertrophy is primarily regulated by internal biological variables (e.g., mechanotransduction, mTORC1 signaling, ribosomal biogenesis) rather than external programming alone, with internal variables acting as the dominant determinant of the hypertrophic response.

To maximize muscle growth, focus on consistent resistance training that provides mechanical load. Your body's internal biological machinery (signaling pathways, gene expression) will determine how much muscle you build from that load. Don't chase acute hormone spikes or muscle soreness, as these are not the primary drivers of long-term hypertrophy.

Produce prescription programs significantly reduce household food insecurity and improve self-reported health status in both adults and children.

If you are experiencing food insecurity, ask your healthcare provider about produce prescription programs. These programs can provide financial support for buying fruits and vegetables, which may help improve your overall health and reduce stress related to food access.

Two weeks of acute physical inactivity (step count <1,000/day) causes a significant decline in glycemic control and integrated muscle protein synthesis in overweight, prediabetic older adults, and these metabolic impairments fail to recover after two weeks of returning to habitual activity levels.

If you are an older adult with prediabetes, even a short period of reduced activity (fewer than 1,000 steps a day) can worsen your blood sugar control and muscle building processes. Crucially, simply going back to your normal activity level for two weeks may not be enough to fix these issues. You may need to be more proactive, such as engaging in specific exercise or medical management, to prevent these declines and help your body recover faster after periods of inactivity.

Higher consumption of whole fat dairy (at least two servings per day) is associated with a lower prevalence of metabolic syndrome and a lower incidence of hypertension and diabetes compared to zero intake.

If you consume dairy, choosing whole fat options (like whole milk, full-fat yogurt, or cheese) and consuming at least two servings daily is associated with a lower risk of developing metabolic syndrome, high blood pressure, and type 2 diabetes compared to not consuming dairy or consuming only low fat dairy. This association holds across diverse global populations, suggesting that the fat content in dairy may not be detrimental and might even be beneficial for metabolic health when compared to low fat alternatives.

Residing in less walkable neighborhoods is associated with a higher predicted 10-year cardiovascular disease risk compared to residing in highly walkable neighborhoods.

If you live in an area with few shops, poor street connectivity, or low density, your risk for heart disease is higher, even if you try to exercise. To counter this, prioritize utilitarian walking (walking to stores, transit) where possible, and be mindful that your environment is working against you. Seek out walkable pockets or plan active commutes to mitigate the structural disadvantage.

Intensive lifestyle modification (including meal replacements and frequent counseling) combined with semaglutide does not produce significantly greater long-term weight loss than semaglutide alone with brief counseling, suggesting the medication's efficacy may render intensive behavioral interventions redundant for long-term outcomes.

When taking semaglutide, intensive lifestyle programs (like meal replacements and frequent counseling) do not significantly improve long-term weight loss compared to brief counseling. The medication's effect is so strong that it largely overrides the need for intensive behavioral strategies for weight loss, though lifestyle changes remain important for health.

Incretin-mimetic drugs (IMDs) such as semaglutide and tirzepatide cause significant skeletal muscle mass loss (≥10%) during rapid weight reduction, a loss comparable to 20 years of age-related decline.

If you are taking GLP-1 or GIP/GLP-1 drugs, expect to lose muscle along with fat. This is not just 'water weight'; it is functional tissue. To mitigate this, you must prioritize protein intake and engage in resistance training, as these are the only proven strategies to preserve muscle during rapid weight loss.

Long-term use of GLP-1 receptor agonists (GLP-1RAs) reduces the incidence of knee surgery and slows cartilage loss velocity in knee osteoarthritis (KOA) patients with comorbid type 2 diabetes, primarily mediated by significant weight loss rather than direct anti-inflammatory effects.

If you have knee osteoarthritis and type 2 diabetes, using GLP-1RAs (like semaglutide or liraglutide) for at least two years can significantly reduce your risk of needing knee surgery and slow down cartilage wear. This benefit comes mainly from the weight loss these drugs cause, which reduces stress on your knees. While they also help with pain, the structural protection is largely weight-dependent. To maximize benefits, combine GLP-1RA therapy with resistance training to preserve muscle mass.

Maintenance of weight loss is physiologically distinct from active weight loss, characterized by a 'perfect physiological storm' of increased appetite and decreased energy expenditure that actively opposes weight maintenance.

Accept that maintaining weight loss is biologically harder than losing it. Your body will fight back with increased hunger and lower energy expenditure. To succeed, you must implement strategies that account for this 'storm,' such as higher physical activity levels to offset the metabolic slowdown, rather than relying solely on willpower or extreme restriction.

Leptin repletion to pre-weight-loss levels reverses most physiological adaptations (hypometabolism and hyperphagia) in weight-reduced individuals, proving that low leptin drives these adaptations.

While leptin therapy is not currently a standard commercial treatment for obesity, this research highlights that the biological drive to regain weight is mediated by low leptin levels. This underscores why weight maintenance is so difficult and why future pharmacotherapies targeting these pathways (like GLP-1 agonists which mimic satiety signals) are crucial.